thyroid gland anaplastic carcinoma
Showing 1 - 7 of 7
Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma Trial in Houston, Salt Lake City (procedure, drug,
Recruiting
- Thyroid Gland Anaplastic Carcinoma
- Thyroid Gland Squamous Cell Carcinoma
- Conventional Surgery
- +5 more
-
Stanford, California
- +5 more
Jan 26, 2023
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,
Recruiting
- BRAF NP_004324.2:p.V600E
- +2 more
- Dabrafenib
- +2 more
-
Duarte, California
- +1 more
Jan 19, 2023
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Thyroid Gland Anaplastic Carcinoma Trial in United States (radiation, drug, other)
Completed
- Thyroid Gland Anaplastic Carcinoma
- Intensity-Modulated Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +129 more
Jun 28, 2022
Thyroid Gland Anaplastic Carcinoma Trial in Saint Petersburg (Dabrafenib, Trametinib)
Recruiting
- Thyroid Gland Anaplastic Carcinoma
-
Saint Petersburg, Russian FederationSaint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
Feb 3, 2021
Recurrent Thyroid Gland Carcinoma, Stage III Differentiated Thyroid Gland Carcinoma AJCC v7, Stage III Thyroid Gland Medullary
Completed
- Recurrent Thyroid Gland Carcinoma
- +12 more
- Laboratory Biomarker Analysis
- Pazopanib Hydrochloride
-
Scottsdale, Arizona
- +21 more
Feb 4, 2020